Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Cerenome (XMP1) vs. Competitors

3 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:XMP1CerenomeEUR 0.59EUR 6.26M-0.15-97.92%Strong BuyUnlock the DE:XMP1 analyst price target with TipRanks PremiumDE:XMP1Unlock the DE:XMP1 top-analyst price target with TipRanks Premium
TVRDTvardi Therapeutics$0.95$12.64M-0.35-75.93%Moderate BuyUnlock the TVRD analyst price target with TipRanks PremiumDE:XMP1 vs TVRDUnlock the TVRD top-analyst price target with TipRanks Premium
SNTISenti Biosciences$2.79$7.25M-0.06-95.20%―Unlock the SNTI analyst price target with TipRanks PremiumDE:XMP1 vs SNTIUnlock the SNTI top-analyst price target with TipRanks Premium
ACRVAcrivon Therapeutics, Inc.$1.40$60.08M-0.77-40.68%Moderate BuyUnlock the ACRV analyst price target with TipRanks PremiumDE:XMP1 vs ACRVUnlock the ACRV top-analyst price target with TipRanks Premium

Performance Comparison

-100%-75%-50%-25%0%25%50%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:XMP1Cerenome0.58-27.56-97.92%
TVRDTvardi Therapeutics0.95-2.97-75.87%
SNTISenti Biosciences2.79-61.23-95.64%
ACRVAcrivon Therapeutics, Inc.1.40-0.90-39.13%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts